- NNPC, Renaissance JV provides $300,000 to keep the National Hospital’s LINAC machine fully operational, preventing treatment delays and maintaining precision care.
- The machine has treated over 2,000 patients, cut therapy time by 80%, and delivered subsidised care to 712 indigent patients, strengthening Nigeria’s cancer treatment capacity.
The NNPC/Renaissance Joint Venture (JV) donated $300,000 to the National Hospital, Abuja, to support the maintenance of its Linear Accelerator (LINAC) radiotherapy machine, ensuring uninterrupted access to treatment for cancer patients.
The JV installed the machine in 2019 as part of a corporate social responsibility programme. It included training medical staff, installing supporting systems, and improving the hospital’s cancer treatment ecosystem.
Meanwhile, Oluwaseyi Omotowa, Chief Upstream Investment Officer of NNPC Upstream Investment Management Services, said the funding prevents disruptions from maintenance gaps. “Regular maintenance ensures the machine operates at full capacity and delivers precise treatment,” he said.
The LINAC machine has treated more than 2,000 patients, reduced therapy time from 12 minutes to two minutes per session, and cut treatment costs by 80%. The hospital has also provided subsidised care for 712 indigent patients, covering 25% to 100% of their treatment.
Furthermore, Coordinating Minister of Health and Social Welfare Ali Pate praised the donation, saying it aligns with President Bola Tinubu’s focus on health sector investment. Chief Medical Director Muhammad Raji Mahmud said the support strengthens local cancer care and reduces reliance on treatment abroad.
Tony Attah, Managing Director of Renaissance Africa Energy Company, also described the funding as a long-term investment in Nigeria’s healthcare system.
Cancer remains a leading cause of death in Nigeria, with over 100,000 new cases annually. The LINAC machine, supported by this donation, will sustain continuous treatment and improve survival rates.